Read: Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up? Medicare currently ...

Unlike the Medicare Part D coverage exclusion, the Medicaid exclusion is permissive: States may, but do not have to, exclude “agents used for weight loss” from coverage. As of August 2024, 13 state ...

such as Wegovy, an injectable prescription weight loss medicine that has helped ... “Employers will consider that the Medicare program has expanded coverage,” said Tracy Spencer, pharmacy ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...

In fact, in March 2024, with the introduction of new and popular AOMs (e.g., Ozempic, Wegovy, and Zepbound), CMS issued guidance confirming that “all drugs used for weight loss have been excluded from ...

President Joe Biden wants Medicare and Medicaid to cover weight-loss drugs, a proposal that would expand access to the costly ...

The Biden administration has called for Medicare and Medicaid to expand coverage of weight-loss drugs for people struggling with obesity, not just as a treatment for diabetes. But because that rule ...

He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...